A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda

Coartem is a fixed-dose combination of artemether-lumefantrine that, given in six doses, provides effective treatment for children with uncomplicated Plasmodium falciparum infection in areas with highly endemic and multidrug-resistant malaria. In Rwanda since 2001, amodiaquine+sulfadoxine-pyrimethamine (AQ+SP) has been the first-line treatment, but resistance to this combination has rapidly emerged and spread. Coartem was considered as a possible alternative, and a randomised, open-label, clinical trial to test its safety, tolerability and efficacy was carried out in 2004-2005. Five hundred children aged 12-59 months with uncomplicated P. falciparum malaria were randomly allocated to AQ+SP or Coartem. Patients were followed up until day 28 after treatment. Adverse events and clinical and parasitological outcomes were recorded. Adequate clinical and parasitological response (ACPR) was significantly higher in children treated with Coartem than in those treated with AQ+SP: the PCR-adjusted 28-day ACPR was 96.68% for Coartem and 79.35% for AQ+SP. Both treatments rapidly cleared parasitaemia and fever, although parasite clearance was significantly faster in children treated with Coartem. Mean packed cell volume increased in all patients, with no significant differences between treatments. Coartem proved to be more efficacious than AQ+SP, with a good safety and tolerability profile.     

拉萨S0S儿童村家庭膳食的调查与评价

[目的]了解中国拉萨SOS儿童村儿童的膳食结构及营养状况,并根据膳食调查结果和存在的问题,提出合理膳食建议。[方法]2005年12月采用食物称重法,对中国拉萨SOS儿童村负责供养168名4～16岁儿童的17户家庭进行了为期5 d的膳食调查。[结果]17户家庭中绝大部分家庭膳食模式不尽合理,油脂摄入过多,大部分家庭脂肪供热百分比﹥30%;动物性食品摄入量及品种偏少,致使所有家庭的钙摄入量普遍不足,70%左右家庭的核黄素、40%左右家庭的蛋白质摄入量不足;多数家庭维生素A和铁虽然超出供给量标准,但是来源于动物性食品的比例很低。[结论]膳食模式的不合理性,势必影响儿童的正常发育和身心健康。因此,进一步加强营养知识的传授显得极为迫切和必要。     

二醋吗啡依赖患者血细胞胎盘型谷胱甘肽S-转移酶mRNA的表达

定量RT-PCR检测33例二醋吗啡依赖患者和19例正常对照血细胞中的胎盘型谷胱甘肽S-转移酶（GST-π）表达水平,同时用银染法检测患者T细胞的核仁机化区（NOR)面积比（Ag-NOR）. 结果表明二醋吗啡依赖患者血细胞中GST-π表达水平明显高于正常对照,但与性别,吸毒时间和吸毒方式无关.     

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

In Rwanda, amodiaquine+sulfadoxine/pyrimethamine (AQ+SP) is the current first-line treatment for malaria, introduced in 2001 as an interim strategy before the future deployment of an artemisinin-based combination treatment (ACT). Dihydroartemisinin/piperaquine (DHA-PQP) is a new co-formulated and well tolerated ACT increasingly used in Southeast Asia where it has proved to be highly effective against Plasmodium falciparum malaria. We tested the efficacy, safety and tolerability of DHA-PQP in children with uncomplicated P. falciparum malaria. A randomised, open trial was carried out in 2003-2004. Seven hundred and sixty-two children aged 12-59 months with uncomplicated P. falciparum malaria were randomly allocated to one of the following treatments: amodiaquine+artesunate; AQ+SP; or DHA-PQP. Patients were followed-up until Day 28 after treatment. Adverse events and clinical and parasitological outcomes were recorded. Children treated with DHA-PQP or AQ+AS had a significantly higher cure rate compared with those treated with amodiaquine+sulfadoxine/pyrimethamine (95.2% and 92.0% vs. 84.7%, respectively). Parasite clearance was significantly faster in children treated with DHA-PQP and AQ+AS compared with those treated with amodiaquine+sulfadoxine/pyrimethamine. The frequency of adverse events was significantly lower in patients treated with DHA-PQP than in those treated with combinations containing amodiaquine. A 3-day treatment with DHA-PQP proved to be efficacious with a good safety and tolerability profile and could be a good candidate for the next first-line treatment.     

咪唑斯汀治疗慢性荨麻疹临床疗效评价及对血清IL-4水平的影响

目的：评价咪唑斯汀治疗慢性荨麻疹的疗效，探讨IL-4在慢性荨麻疹发病中的作用。方法：对32例慢性荨麻疹患用咪唑斯汀治疗，评价疗效，记录不良反应。同时用ELISA法检测慢性荨麻疹患治疗前后及正常人血清IL-4的水平。结果：治疗1、2wk后总有效率分别为62．5％、84．4％(P＜0．01)，不良反应3例。治疗前血清IL-4水平较正常人明显升高(P＜0．01)；治疗后IL-4水平下降(P＜0．01)，与正常人比较差异不甚明显(P＞0．05)。结论：咪唑斯汀是一种有效、安全的治疗慢性荨麻疹的药物，能降低慢性荨麻疹患血清IL-4的水平。     

石油沥青对职业人群健康影响的调查

目的调查长期接触石油沥青对职业人群健康的影响，为制订职业卫生标准提供职业流行病学调查资料。方法对防水材料生产企业和石油沥青暴露人群进行作业场所劳动卫生学和职业流行病学调查。结果对石油沥青暴露组394人，对照组237人调查结果表明，暴露组失眠、胸闷、鼻干等症状出现率高于对照组，其他检查显示，暴露组肺纹理增强、支气管炎出现率虽高于对照组，但无统计学意义。结论作业场所石油沥青烟浓度为0．69—10．46mg／m^3的情况下，石油沥青对职业人群健康没有产生明显的损害作用，也没有发现特异性损害。     

2018年西藏地区居民住院服务利用情况分析

目的 分析2018年西藏地区居民住院服务利用的情况,了解现状并为相关部门合理配置资源提供依据。方法 用多阶段分层整群随机抽样的方法,对15岁及以上西藏居民的住院情况进行统计分析,共10 501份问卷,采用描述性分析、χ2检验及logistic回归分析。结果 2018年西藏地区15岁及以上居民住院率为8.2%,住院原因中消化系统疾病占比（22.0%）最高;需住未住率为1.4%,未住原因中其他原因占比（38.4%）最高,其次为经济困难（29.1%）。多因素分析中男性（OR:1.788,95%CI:1.535～2.083）、45~54岁（OR:3.319,95%CI:2.457～4.483）、未在婚（OR:1.704,95%CI:1.408～2.062）、自评健康分值良好（OR:2.423,95%CI:1.842～3.189）、不患慢性病（OR:2.208,95%CI:1.871～2.605）是住院的保护因素。结论 2018年西藏地区住院率及住院服务利用低,多种因素影响居民住院情况,应根据实际需求实施有针对性的措施。     

乌龙丹联合柳氮磺吡啶治疗强直性脊柱炎36例

目的：观察乌龙丹联合柳氮磺吡啶治疗强直性脊柱炎的疗效与安全性。方法：66例门诊患者随机分为治疗组36例和对照组30例,治疗组给予乌龙丹联合柳氮磺吡啶治疗,对照组给予柳氮磺吡啶治疗,两组均在必要时给予NSAIDs治疗并记录剂量及用药天数。观察治疗前后两组患者临床疗效及实验室指标改变情况。结果：治疗12周后,两组患者在晨僵时间、ESR、CRP、BASFI、BASDAI均比治疗前有显著改善（P＜0．05）,且治疗组优于对照组（P＜0．05）。治疗组有效率高于对照组（P＜0．05）,且不良反应较对照组少（ P＜0．05）。结论：乌龙丹联合柳氮磺吡啶治疗强直性脊柱炎有良好疗效。     

Biomechanical strains on the hand-wrist system during grapevine pruning

OBJECTIVES: In order to understand the high prevalence of musculoskeletal disorders of the hand among vineyard workers, we conducted a study to evaluate biomechanical strains on the hand-wrist system during grapevine pruning. METHODS: Surface electromyography (sEMG) activity of the right flexor digitorum muscle and wrist posture were analysed in six healthy vineyard workers using the same hand-powered pruning shears during grapevine pruning. RESULTS: The biomechanical strains on the hand-wrist system were high during grapevine pruning. Mean sEMG activity during pruning was high [23.5% (standard error of the mean (SEM): 0.4) in the maximal voluntary handgrip contraction (MVC)], as was the mean cutting frequency per minute (38; range=24-48). Approximately 14% of cuts were performed with the wrist in extreme flexion/extension (F/E) (>60% of the maximum range). Numerous cuts required moderate (20%-40% of the maximum range) or extreme (>50% of the maximum range) ulnar deviation (17% and 12% of cuts, respectively). Approximately 18% of cuts required both high muscular activity (sEMG >15% MVC) and extreme ulnar/radial (U/R) deviation of the wrist (>50% of the maximum range). CONCLUSION: Pruning imposes high biomechanical strains on the hand-wrist system in view of the repetitiveness of the task. The magnitude of physical exposure during pruning explains the high prevalence of hand disorders among vineyard workers. The use of ergonomic pruning shears is advised to lower force exertion and to reduce the frequency of awkward wrist postures during pruning.     

FEASIBILITY OF CONDUCTING CARDIOVASCULAR OUTCOME RESEARCH IN AUSTRALIAN GENERAL PRACTICE: RESULTS FROM THE ANBP2 PILOT STUDY

1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial.